Disability News and Research

RSS

Comprehensive insight into current neural stem cell research and therapies

A new article published by Cell Press in the May 26 issue of the journal Neuron provides comprehensive insight into the current status of neural stem cell research and the sometimes labyrinthine pathways leading to stem cell-based therapies.

26 May 2011

Pulmonx announces new clinical data of Zephyr endobronchial valve in emphysema

Pulmonx Inc. has announced new clinical data from its Chartis multi-center study, presented at the American Thoracic Society's 2011 International Conference.

25 May 2011

MKK4 enzyme may prevent arrhythmias linked with cardiac hypertrophy

Scientists have discovered an important enzyme molecule that may prevent fatal cardiac disorders associated with cardiac hypertrophy - the leading cause of sudden cardiac death in young athletes.

25 May 2011

Biogen Idec joins global multiple sclerosis community to celebrate third annual World MS Day

Today, Biogen Idec will join the global multiple sclerosis (MS) community in celebrating the third annual World MS Day. Biogen Idec continues to be the industry leader in researching and providing groundbreaking therapies for MS. So far in 2011, the company has brought more hope to MS patients through a number of significant milestones.

25 May 2011

Study to explore whether early depression treatment can reduce risk of heart disease

Jesse Stewart, Ph.D., assistant professor of psychology in the School of Science at Indiana University-Purdue University Indianapolis and an Indiana University Center for Aging Research affiliated scientist, has received a $110,000 grant from the American Heart Association to explore whether treatment of depression before one experiences a heart attack can reduce the likelihood of future heart disease.

25 May 2011

Vectra DA blood test may help predict patients' response to rheumatoid arthritis therapy

Crescendo Bioscience- today announced data indicating that Vectra- DA, a first-in-class multi-biomarker blood test used to assess rheumatoid arthritis disease activity, provides physicians with an objective measure which may help determine whether patients are responding to therapy.

25 May 2011

More than 15% of school children have a developmental disability

More than 15 percent of school-age kids — about 10 million children — had a developmental disability in 2006-08, according to a study released Monday in the journal Pediatrics.

24 May 2011

First Edition: May 23, 2011

Today's headlines include reports about a new poll that shows Americans don't believe Medicare has to be cut in order to balance the budget.

23 May 2011

NIH allocated $400 million funding for pain research in 2010

An unprecedented level of federal funding for pain research, some $400 million, was allocated in 2010 by the National Institutes of Health (NIH) through provisions of the American Recovery and Investment Act and the Affordable Care Act to help accelerate advances in pain research, prevention and treatment.

21 May 2011

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

The American Pain Society, www.ampainsoc.org, today honored the recipients of its fifth annual Clinical Centers of Excellence in Pain Management Awards recognizing the nation's outstanding pain care centers.

21 May 2011

EMA CHMP recommends conditional marketing authorization of FAMPYRA

The Committee for Medicinal Products for Human Use of the European Medicine Agency has recommended conditional marketing authorization of FAMPYRA (prolonged-release fampridine 10 mg tablets) for the improvement of walking in adult patients with multiple sclerosis with walking disability.

20 May 2011

EMA CHMP recommends positive opinion for marketing authorization of Amgen's XGEVA

Amgen today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended a positive opinion for the marketing authorization of XGEVA (denosumab) for the prevention of skeletal-related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with bone metastases from solid tumors.

20 May 2011

Osteoarthritis directly linked to low-fat, high-carb food

Osteoarthritis is a degenerative joint disease and the most common cause of disability today. It was once considered a problem of the old but it is now commonly diagnosed in those as young as the mid-twenties and early thirties. According to the Arthritis Foundation, about four million, quality-adjusted life years are lost due to knee osteoarthritis alone.

20 May 2011

Breakthrough injectable gel for treating degeneration of the intervertebral disc

Chronic lower back pain is a major problem for society - behind only headaches as the most common neurological ailment - and is frequently caused by degeneration of the intervertebral disc.

From The University of Manchester 20 May 2011

VIDAS TOXO IgG Avidity assay to test for recent Toxoplasma gondii infection receives FDA clearance

On May 18, the U.S. Food and Drug Administration cleared the first test to help determine whether a pregnant woman or a person with swollen lymph nodes testing positive for toxoplasmosis, sometimes known as cat scratch disease, developed the infection within the past four months.

20 May 2011

First Edition: May 19, 2011

Today's headlines continue to analyze the impact of the departure of Sen. Tom Coburn, R-Okla., from the 'Gang of Six' on the efforts to address long-term budget issues such as Medicare spending.

19 May 2011

Pitt researchers develop mouse model of major depressive disorder

Researchers at the University of Pittsburgh School of Medicine have developed a mouse model of major depressive disorder (MDD) that is based on a rare genetic mutation that appears to cause MDD in the majority of people who inherit it.

19 May 2011

Musculoskeletal pain, obesity and smoking linked to increased risk of back-related disability

Musculoskeletal pain, obesity, and smoking are among the factors associated with an increased risk of work disability due to low back disorders, reports a study in the May Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.

19 May 2011

Fragile X syndrome may be treatable

Advancements over the last 10 years in understanding intellectual disability (ID, formerly mental retardation), have led to the once-unimaginable possibility that ID may be treatable, a review of more than 100 studies on the topic has concluded. It appears in ACS Chemical Neuroscience.

18 May 2011

Treatment of chronic low back pain can reverse abnormal brain activity and function

It likely comes as no surprise that low back pain is the most common form of chronic pain among adults. Lesser known is the fact that those withchronic pain also experience cognitive impairments and reduced gray matter in parts of the brain associated with pain processing and the emotional components of pain, like depression and anxiety.

18 May 2011

Disability News and Research

Comprehensive insight into current neural stem cell research and therapies

Pulmonx announces new clinical data of Zephyr endobronchial valve in emphysema

MKK4 enzyme may prevent arrhythmias linked with cardiac hypertrophy

Biogen Idec joins global multiple sclerosis community to celebrate third annual World MS Day

Study to explore whether early depression treatment can reduce risk of heart disease

Vectra DA blood test may help predict patients' response to rheumatoid arthritis therapy

More than 15% of school children have a developmental disability

First Edition: May 23, 2011

NIH allocated $400 million funding for pain research in 2010

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

EMA CHMP recommends conditional marketing authorization of FAMPYRA

EMA CHMP recommends positive opinion for marketing authorization of Amgen's XGEVA

Osteoarthritis directly linked to low-fat, high-carb food

Breakthrough injectable gel for treating degeneration of the intervertebral disc

VIDAS TOXO IgG Avidity assay to test for recent Toxoplasma gondii infection receives FDA clearance

First Edition: May 19, 2011

Pitt researchers develop mouse model of major depressive disorder

Musculoskeletal pain, obesity and smoking linked to increased risk of back-related disability

Fragile X syndrome may be treatable

Treatment of chronic low back pain can reverse abnormal brain activity and function

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News